MediciNova to Sell Common Shares, Preferred Shares to Kissei
MediciNova Inc. (MNOV) plans to sell to Kissei Pharmaceutical Co. 800,000 common shares for $2 million and 220,000 preferred shares for $5.5 million.
The share sale was disclosed in filings today with Japan’s finance ministry.
To contact the editor responsible for this story: Taku Kato at email@example.com
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.